Keywords: biotech, holdings, starts, new, diabetes, trials, vancouver

Biotech Holdings Starts New Diabetes Trials

Article | 15 April 1996

Print This

Biotech Holdings of Vancouver, Canada, has started a four-month clinical trial of V-411, its oral hypoglycemic for type II diabetes. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in